ATHX

Athersys (ATHX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATHX
DataOraFonteTitoloSimboloCompagnia
08/01/202413:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATHXAthersys Inc
21/12/202317:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
16/11/202314:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATHXAthersys Inc
16/10/202322:52Business WireAthersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic AlternativesNASDAQ:ATHXAthersys Inc
10/10/202314:30Business WireAthersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with HealiosNASDAQ:ATHXAthersys Inc
03/10/202322:30Business WireAthersys Licenses its Animal Health Assets to Ardent Animal HealthNASDAQ:ATHXAthersys Inc
02/10/202323:04Business WireAthersys Director Jane Wasman Appointed Board ChairNASDAQ:ATHXAthersys Inc
25/09/202322:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ATHXAthersys Inc
22/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATHXAthersys Inc
19/09/202303:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ATHXAthersys Inc
14/09/202316:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATHXAthersys Inc
13/09/202323:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATHXAthersys Inc
06/09/202320:45Business WireGrant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney TransplantationNASDAQ:ATHXAthersys Inc
21/08/202320:36Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ATHXAthersys Inc
18/08/202303:30Business WireAthersys, Inc. Announces Pricing of $3.5 Million Public OfferingNASDAQ:ATHXAthersys Inc
17/08/202322:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATHXAthersys Inc
16/08/202323:01Business WireAthersys Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
11/08/202314:00Business WireAthersys Appoints Neema Mayhugh, PhD to its Board of DirectorsNASDAQ:ATHXAthersys Inc
07/08/202323:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ATHXAthersys Inc
31/07/202319:38Business WireAthersys to Host Business Update Conference Call on August 9thNASDAQ:ATHXAthersys Inc
14/07/202322:31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ATHXAthersys Inc
14/07/202322:16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ATHXAthersys Inc
28/06/202312:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATHXAthersys Inc
08/06/202316:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ATHXAthersys Inc
08/06/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ATHXAthersys Inc
01/06/202322:40Business WirePatient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic TraumaNASDAQ:ATHXAthersys Inc
26/05/202323:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ATHXAthersys Inc
23/05/202314:30Business WireAthersys Restructures Debt with SupplierNASDAQ:ATHXAthersys Inc
18/05/202315:58Business WireAthersys Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:ATHXAthersys Inc
15/05/202322:54Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATHXAthersys Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATHX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network